HighTower Advisors
CLBT icon

HighTower Advisors’s Cellebrite CLBT Stock Holding History

HighTower Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,439
Closed -$171K – 3839
2026
Q1 		$171K Buy
+12,439
New +$187K ﹤0.01% 3535
2025
Q2 		– Sell
-14,485
Closed -$281K – 3788
2025
Q1 		$281K Buy
14,485
+2,029
+16% +$42.7K ﹤0.01% 2917
2024
Q4 		$274K Buy
+12,456
New +$240K ﹤0.01% 2951

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

HighTower Advisors's CLBT Position: Q2 2026 in Review

HighTower Advisors sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 12,439 shares — an estimated $171K sold.

HighTower Advisors first reported a position in CLBT in Q4 2024 and held it in 3 quarters. The position peaked at $281K in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • HighTower Advisors reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • HighTower Advisors sold 12,439 Cellebrite shares in Q2 2026, an estimated $171K.
  • HighTower Advisors first reported a position in Cellebrite in Q4 2024 and held it in 3 quarters.
  • HighTower Advisors's Cellebrite position peaked at $281K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.